Current status: Answered by Jenni Minto on 27 May 2025
To ask the Scottish Government whether it will write to the UK Government to seek clarity on what steps can be taken to expand access to tovorafenib.
The regulations for the licensing, safety and efficacy of medicines are reserved to the UK Government and are the responsibility of the Medicines and Healthcare products Regulatory Agency (MHRA). For a medicine to be routinely prescribed in the UK, it firstly needs to receive a marketing authorisation. This process ensures the safety, quality and efficacy of medicines placed on the market in the UK. It is the responsibility of individual pharmaceutical companies to apply to the MHRA for a marketing authorisation.